Clinical trial
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.
NCT04122742 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 8, 2019
- Completion date
- October 31, 2025
- Enrollment
- 154 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.